Aclaris Therapeutics Gets Buy Rating and PT Raised to $16 by HC Wainwright & Co.

miércoles, 28 de enero de 2026, 8:48 am ET1 min de lectura
ACRS--

Aclaris Therapeutics Gets Buy Rating and PT Raised to $16 by HC Wainwright & Co.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios